Tropoelastin Promoter and Crosslinker Composition for Skin Elasticity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for skin aging primarily focus on inhibiting elastin degradation or promoting elastin production but lack a synergistic approach to stimulate tropoelastin production and crosslinking simultaneously, which is essential for effectively addressing signs of skin aging such as wrinkles, loss of elasticity, and uneven skin tone.

Innovation Solution

A topical composition combining a tropoelastin promoter, such as blackberry extract, and a tropoelastin crosslinker, like dill extract, to enhance the production and crosslinking of tropoelastin, thereby improving skin elasticity and reducing signs of aging.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If only elastin degradation is inhibited or only elastin production is promoted, then partial improvement in skin elasticity is achieved, but the synergistic effect of simultaneous tropoelastin production stimulation and crosslinking is not realized

Engineering Contradiction:
Improveskin elasticityVSAvoidtropoelastin production and crosslinking efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent combines two previously separate treatment approaches into a single synergistic composition: (1) promoting tropoelastin production using agents like retinoids, ferulic acid, or resveratrol, and (2) stimulating tropoelastin crosslinking using agents like copper peptides or lysyl oxidase. This merging of production promotion and crosslinking stimulation into one formulation creates a synergistic effect that significantly improves skin elasticity beyond what either approach could achieve alone.

Inventive Principle:
Principle #5Merging (Combining)

2Reliability

If separate treatments are used for elastin production promotion and crosslinking, then individual effects are achieved, but the combined synergistic efficacy is not obtained

Engineering Contradiction:
Improveskin elasticityVSAvoidtreatment composition complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent creates a universal topical composition that performs multiple functions simultaneously: it promotes tropoelastin production, stimulates crosslinking, and improves skin elasticity. The formulation includes both production-promoting agents (such as retinoids, ferulic acid, or resveratrol) and crosslinking-stimulating agents (such as copper peptides or lysyl oxidase) in a single multi-functional product, eliminating the need for separate treatments while achieving synergistic effects.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The synergistic effect of the composition significantly improves skin elasticity, reduces wrinkles, and enhances skin tone, demonstrating a more effective treatment for skin aging compared to separate approaches.

Implementation Method 1

retinoids up-regulate elastin production in fibroblasts

Methodology Applied
Scientific EffectProtein synthesis up-regulation:

Implementation Method 2

lysyl oxidase serves as a crosslinking enzyme and an element of the scaffold to ensure spatially defined deposition of elastin

Methodology Applied
Scientific EffectEnzymatic crosslinking: Enzyme

Implementation Method 3

matrix metalloproteinases (MMPs), a group of enzymes that are able to break down macromolecules in the extracellular matrix, play an important role in elastin degradation

Methodology Applied
Scientific EffectEnzyme inhibition: Enzyme

Data Source

PatentEP2246042B1Compositions for treating signs of skin aging
Publication Date: 2018.09.26 JOHNSON & JOHNSON CONSUMER INC

AI summary

The invention relates to methods and compositions for treating skin aging, said compositions comprising at least one tropoelastin promoter and at least one tropoelastin crosslinker.